These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10361121)

  • 21. Hereditary Antithrombin Deficiency Presenting with Deep Venous Thrombosis During the Second Pregnancy.
    Yamashita M; Komaki T; Tashiro K; Inada Y; Iwata A; Ogawa M; Morishita E; Miura SI
    Intern Med; 2020 Jan; 59(2):235-239. PubMed ID: 31554754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect.
    de la Morena-Barrio ME; Martínez-Martínez I; de Cos C; Wypasek E; Roldán V; Undas A; van Scherpenzeel M; Lefeber DJ; Toderici M; Sevivas T; España F; Jaeken J; Corral J; Vicente V
    J Thromb Haemost; 2016 Aug; 14(8):1549-60. PubMed ID: 27214821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pleiotropic effects of antithrombin strand 1C substitution mutations.
    Lane DA; Olds RJ; Conard J; Boisclair M; Bock SC; Hultin M; Abildgaard U; Ireland H; Thompson E; Sas G
    J Clin Invest; 1992 Dec; 90(6):2422-33. PubMed ID: 1469094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safe childbirth for a type 1 antithrombin-deficient woman with novel mutation in the SERPINC1 gene undergoing antithrombin concentrate therapy.
    Ikeda Y; Yamanouchi J; Hato T; Yasukawa M; Takenaka K
    Blood Coagul Fibrinolysis; 2019 Jan; 30(1):47-51. PubMed ID: 30431449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical and genetic analysis of a pedigree affected with type I hereditary antithrombin deficiency due to a g.2736dupT variant of the AT gene].
    Yang X; Shu K; Chen J; Li F; Wang X; Yang W; Yao Y; Ai X; Chen B; Jiang M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Nov; 37(11):1250-1252. PubMed ID: 33179232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High levels of latent antithrombin in plasma from patients with antithrombin deficiency.
    de la Morena-Barrio M; Sandoval E; Llamas P; Wypasek E; Toderici M; Navarro-Fernández J; Rodríguez-Alen A; Revilla N; López-Gálvez R; Miñano A; Padilla J; de la Morena-Barrio B; Cuesta J; Corral J; Vicente V
    Thromb Haemost; 2017 May; 117(5):880-888. PubMed ID: 28229161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel SERPINC1 frameshift mutation in two antithrombin deficiency families.
    Zhang D; Sun B; Zhang X; Li H; Lin Y; Qin L; Chen L; Zhang L; Ru K; Yang R
    Int J Lab Hematol; 2020 Apr; 42(2):e48-e51. PubMed ID: 31441586
    [No Abstract]   [Full Text] [Related]  

  • 28. Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a beta-like variant in baculovirus-infected insect cells.
    Ersdal-Badju E; Lu A; Peng X; Picard V; Zendehrouh P; Turk B; Björk I; Olson ST; Bock SC
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):323-30. PubMed ID: 7646463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene.
    Picard V; Nowak-Göttl U; Biron-Andreani C; Fouassier M; Frere C; Goualt-Heilman M; de Maistre E; Regina S; Rugeri L; Ternisien C; Trichet C; Vergnes C; Aiach M; Alhenc-Gelas M
    Hum Mutat; 2006 Jun; 27(6):600. PubMed ID: 16705712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombin heparin binding site deficiency: A challenging diagnosis of a not so benign thrombophilia.
    Orlando C; Heylen O; Lissens W; Jochmans K
    Thromb Res; 2015 Jun; 135(6):1179-85. PubMed ID: 25837307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombin p.Thr147Ala: The First Founder Mutation in People of African Origin Responsible for Inherited Antithrombin Deficiency.
    Orlando C; de la Morena-Barrio B; Pareyn I; Vanhoorelbeke K; Martínez-Martínez I; Vicente V; Corral J; Jochmans K; de la Morena-Barrio ME
    Thromb Haemost; 2021 Feb; 121(2):182-191. PubMed ID: 32920809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional antithrombin-III variant (41 Pro----Leu) identified by liquid secondary ion mass spectrometry.
    Brennan SO; Borg JY; Shaw GJ; Caen J; George PM
    Pathology; 1991 Jan; 23(1):1-4. PubMed ID: 2062560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New carbohydrate site in mutant antithrombin (7 Ile----Asn) with decreased heparin affinity.
    Brennan SO; Borg JY; George PM; Soria C; Soria J; Caen J; Carrell RW
    FEBS Lett; 1988 Sep; 237(1-2):118-22. PubMed ID: 3169232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombin-p.Ala416Pro: the second reported case in Japan.
    Shigekiyo T; Sekimoto E; Shibata H; Ozaki S; Kurushima A; Aihara K
    Intern Med; 2014; 53(5):477-81. PubMed ID: 24583439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five antithrombin variants, four associated with thrombosis.
    Fitton HL; Walker ID; Jones L; Brown K; Carrell RW; Coughlin P
    Blood Coagul Fibrinolysis; 1997 Mar; 8(2):145-8. PubMed ID: 9518046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity.
    Olson ST; Frances-Chmura AM; Swanson R; Björk I; Zettlmeissl G
    Arch Biochem Biophys; 1997 May; 341(2):212-21. PubMed ID: 9169007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.
    Okajima K; Abe H; Wagatsuma M; Okabe H; Takatsuki K
    Am J Hematol; 1995 Jan; 48(1):12-8. PubMed ID: 7832187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformational Asn187Asp/Lys antithrombin variants and thrombosis. Clinical and biological features in 13 new heterozygotes.
    Picard V; Bauters A; Khairy M; Ochat N; Jude B; Aiach M; Alhenc-Gelas M
    Thromb Haemost; 2005 Jan; 93(1):57-62. PubMed ID: 15630491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased N-glycosylation efficiency by generation of an aromatic sequon on N135 of antithrombin.
    Aguila S; Martínez-Martínez I; Dichiara G; Gutiérrez-Gallego R; Navarro-Fernández J; Vicente V; Corral J
    PLoS One; 2014; 9(12):e114454. PubMed ID: 25485983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A frameshift mutation leading to type 1 antithrombin deficiency and thrombosis.
    Olds RJ; Lane DA; Finazzi G; Barbui T; Thein SL
    Blood; 1990 Dec; 76(11):2182-6. PubMed ID: 1979501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.